DENDREON CORP's ticker is DNDNQ and the CUSIP is 24823Q107. A total of 118 filers reported holding DENDREON CORP in Q3 2014. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $31,000 | -71.6% | 13,890 | -63.8% | 0.00% | -75.0% |
| Q1 2014 | $109,000 | -20.4% | 38,340 | -20.0% | 0.01% | -27.3% |
| Q4 2013 | $137,000 | +204.4% | 47,938 | +179.4% | 0.01% | +266.7% |
| Q3 2013 | $45,000 | -87.6% | 17,155 | -80.7% | 0.00% | -89.7% |
| Q2 2013 | $364,000 | – | 88,783 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alden Global Capital Ltd | 2,150,000 | $6,429,000 | 1.62% |
| MANGROVE PARTNERS IM, LLC | 1,290,500 | $3,859,000 | 1.61% |
| MILLER VALUE PARTNERS, LLC | 2,434,000 | $7,278,000 | 0.33% |
| BOLTON LP | 445,571 | $1,332,000 | 0.25% |
| TANG CAPITAL MANAGEMENT LLC | 79,600 | $238,000 | 0.17% |
| BNP PARIBAS FINANCIAL MARKETS | 7,000,000 | $445,340,000,000 | 0.16% |
| Cormorant Asset Management, LP | 150,000 | $449,000 | 0.13% |
| PFM Health Sciences, LP | 2,007,813 | $6,003,000 | 0.12% |
| Partner Investment Management, L.P. | 153,234 | $458,000 | 0.10% |
| Concert Wealth Management Inc. | 272,004 | $812,000 | 0.10% |